The Comparative Safety of Oral Versus Intranasal Desmopressin for the Treatment of Children With Nocturnal Enuresis

Journal of Urology

Volumn 178, Issue 1, 2007, Pages 24-30

  Robson, W L M ^a   Leung, A K C ^a   Norgaard, J P ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

bladder; complications; deamino arginine vasopressin; enuresis; hyponatremia

Indexed keywords

DESMOPRESSIN;

ABDOMINAL PAIN; CHILDHOOD DISEASE; CLINICAL TRIAL; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPEPSIA; EPISTAXIS; HUMAN; HYPONATREMIA; INTERMETHOD COMPARISON; MEDLINE; NAUSEA; NOCTURNAL ENURESIS; NOSE CONGESTION; PRIORITY JOURNAL; REVIEW; RHINITIS; TABLET FORMULATION; VOMITING;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANTIDIURETIC AGENTS; CHILD; DEAMINO ARGININE VASOPRESSIN; HUMANS; HYPONATREMIA; NOCTURNAL ENURESIS; OSMOLAR CONCENTRATION; RISK FACTORS;

EID: 34250324701     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.015     Document Type: Review

References (56)

1. Robson W.L., Norgaard J.P., and Leung A.K. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 155 (1996) 959
2. Burke J.R., Mizusawa Y., Chan A., and Webb K.L. A comparison of amitriptyline, vasopressin and amitriptyline with vasopressin in nocturnal enuresis. Pediatr Nephrol 9 (1995) 438
3. Cendron M., and Klauber G. Combination therapy in the treatment of persistent nocturnal enuresis. Br J Urol, suppl. 3 (1998) 26
4. Chiozza M.L., DelGado R., diToro R., Ferrara P., Fois A., Giorgi P., et al. Italian multicentre open trial on DDAVP spray in nocturnal enuresis. Scand J Urol Nephrol 33 (1999) 42
5. DelGado R., DelGaizo D., Cennamo M., Auriemma R., DelGado G., and Verni M. Desmopressin is a safe drug for the treatment of enuresis. Scand J Urol Nephrol 39 (2005) 308
6. Fjellestad-Paulsen A., Wille S., and Harris A.S. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child 62 (1987) 674
7. Kahan E., Morel D., Amir J., and Zelcer C. A controlled trial of desmopressin and behavioral therapy for nocturnal enuresis. Medicine (Baltimore) 77 (1998) 384
8. Matthiesen T.B., Rittig S., Djurhuus J.C., and Norgaard J.P. A dose titration, and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 151 (1994) 460
9. Miller K., and Klauber G.T. Desmopressin acetate in children with severe primary nocturnal enuresis. Clin Ther 12 (1990) 357
10. Schulman S.L., Stokes A., and Salzman P.M. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. J Urol 166 (2001) 2427
11. Shu S.G., Lii Y.P., and Chi C.S. The efficacy of intranasal DDAVP therapy in children with nocturnal enuresis. Zhonghua Yi Xue Za Zhi (Taipei) 52 (1993) 368
12. Skoog S.J., Stokes A., and Turner K.L. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis. J Urol 158 (1997) 1035
13. Terho P., and Kekomaki M. Management of nocturnal enuresis with a vasopressin analogue. J Urol 131 (1984) 925
14. Terho P. Desmopressin in nocturnal enuresis. J Urol 145 (1991) 818
15. Triantafyllidis A., Charalambous S., Papatsoris A.G., Papathanasiou A., Kalaitzis C., Rombis V., et al. Management of nocturnal enuresis in Greek children. Pediatr Nephrol 20 (2005) 1343
16. Tullus K., Bergstrom R., Fosdal I., Winnergard I., Hjalmas K., and Swedish Enuresis Trial Group. Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatr 88 (1999) 1274
17. Uygur M.C., Ozgu I.H., Ozen H., Ozen S., Toklu C., Ergen A., et al. Long-term treatment of nocturnal enuresis with desmopressin intranasal spray. Clin Pediatr (Phila) 36 (1997) 455
18. VandeWalle J., Bogaert G.A., Mattsson S., Schurmans T., Hoebeke P., Deboe V., et al. A new fast-melting oral formulation of desmopressin (Minirin® Melt): a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int 97 (2006) 603
19. Vertucci P., Lanzi C., Capece G., Fano M., Gallai V., Margari L., et al. Desmopressin and imipramine in the management of nocturnal enuresis: a multicentre study. Br J Clin Pract 51 (1997) 27
20. Wille S. Comparison of desmopressin and enuresis alarm for nocturnal enuresis. Arch Dis Child 61 (1986) 30
21. Wolfish N.M., Barkin J., Gorodzinsky F., and Schwarz R. The Canadian Enuresis Study and Evaluation-short- and long-term safety and efficacy of an oral desmopressin preparation. Scand J Urol Nephrol 37 (2003) 22
22. Yap H.K., Chao S.M., Tan A.Y., Murugasu B., Ong E.K., and Low E.H. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children. J Paediatr Child Health 34 (1998) 151
23. Chiozza M.L., Bernardinelli L., Caione P., DelGado R., Ferrara P., Giorgi P.L., et al. An Italian epidemiological multicentre study of nocturnal enuresis. Br J Urol, suppl. 3 (1998) 86
24. Apakama D.C., and Bleetman A. Hyponatraemic convulsion secondary to desmopressin treatment for primary enuresis. J Accid Emerg Med 16 (1999) 229
25. Bamford M.F., and Cruickshank G. Dangers of intranasal desmopressin for nocturnal enuresis. J R Coll Gen Pract 39 (1989) 345
26. Beach P.S., Beach R.E., and Smith L.R. Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake. Clin Pediatr (Phila) 31 (1992) 566
27. Blanchard P., and Brossier J.P. Convulsions caused by deep hyponatremia during treatment of enuresis with nasal desmopressin. Arch Fr Pediatr 48 (1991) 589
28. Donoghue M.B., Latimer M.E., Pillsbury H.L., and Hertzog J.H. Hyponatremic seizure in a child using desmopressin for nocturnal enuresis. Arch Pediatr Adolesc Med 152 (1998) 290
29. Guillaud R., Amram S., Lememme F., and Lesbros D. Desmopressin and water intoxication. Apropos of a case treated for enuresis. Pediatrie 48 (1993) 697
30. Hamed M., Mitchell H., and Clow D.J. Hyponatraemic convulsion associated with desmopressin and imipramine treatment. BMJ 306 (1993) 1169
31. Hourthane J., and Salisbury A.J. Use caution in prescribing desmopressin for nocturnal enuresis (letter). BMJ 306 (1993) 1545
32. Jensen S.S., and Hansen L.P. Acute water intoxication caused by intranasal desmopression-Minirin. Ugeskr Laeger 159 (1997) 306
33. Kallio J., Rautava P., Huupponen R., and Korvenranta H. Severe hyponatremia caused by intranasal desmopressin for nocturnal enuresis. Acta Paediatr 82 (1993) 881
34. Lebl J., Kolska M., Zavacka A., Eliasek J., Gut J., and Biolek J. Cerebral oedema in enuretic children during low-dose desmopressin treatment: a preventable complication. Eur J Pediatr 160 (2001) 159
35. Muglia L., Goodman E., and Peters C. Symptomatic hyponatremia secondary to DDAVP treatment for primary enuresis. Pediatr Res 31 (1992) 1A
36. Ragoschke-Schumm A., Witte O.W., and Terborg C. Hyponatremic encephalopathy caused by desmopressin-induced hyponatremia. J Neurol 252 (2005) 1411
37. Robson W.L., Shashi V., Nagaraj S., and Norgaard J.P. Water intoxication in a patient with the Prader-Willi syndrome treated with desmopressin for nocturnal enuresis. J Urol 157 (1997) 646
38. Schwab M., Wenzel D., and Ruder H. Hyponatraemia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna. Eur J Pediatr 155 (1996) 46
39. Segal-Kuperschmit D., li-Gotfrid O., and Luder A. Water intoxication following desmopressin overdose. Harefuah 132 (1997) 465
40. Simmonds E.J., Mahony M.J., and Little J.M. Convulsion and coma after intranasal desmopressin in cystic fibrosis. BMJ 297 (1988) 1614
41. Thumfart J., Roehr C.C., Kapelari K., Querfeld U., Eggert P., and Muller D. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors?. J Urol 174 (2005) 294
42. Yaouyanc G., Jonville A.P., Yaouyanc-Lapalle H., Barbier P., Dutertre J.P., and Autret E. Seizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis. J Toxicol Clin Toxicol 30 (1992) 637
43. Dehoorne J.L., Raes A.M., VanLaecke E., Hoebeke P., and VandeWalle J.G. Desmopressin toxicity due to prolonged half-life in 18 patients with nocturnal enuresis. J Urol 176 (2006) 754 discussion 757
44. Ecoffey M., Merz A., Egli D., Panchard M.A., and Laubscher B. Role of the prescribing doctor in hyponatremic seizures of enuretic children on desmopressin. (French). Archives de Pediatrie 13 (2006) 262
45. Schwab M., and Ruder H. Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing. Eur J Pediatr 156 (1997) 668
46. Data on file (2005), Ferring Pharmaceuticals A/S, Copenhagen
47. Richardson D.W., and Robinson A.G. Desmopressin. Ann Intern Med 103 (1985) 228
48. Palm C., and Gross P. V2-vasopressin receptor antagonists mechanism of effect and clinical implications in hyponatraemia. Nephrol Dial Transplant 14 (1999) 2559
49. Andersson K.E., Appell R., Cardozo L., Chapple C., Drutz H., Fourcroy J., et al. Pharmacological treatment of urinary incontinence. In: Abrams P., Cardozo L., Wein A., and Khoury S. (Eds). Incontinence, 3rd International Consultation on Incontinence 2005 (2005), Plymbridge Distributors Ltd, Plymouth, United Kingdom 809-854
50. Fjellestad-Paulsen A., Hoglund P., Lundin S., and Paulsen O. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol (Oxf) 38 (1993) 177
51. Rittig S., Jensen A.R., Jensen K.T., and Pedersen E.B. Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects. Clin Endocrinol (Oxf) 48 (1998) 235
52. Rembratt A., Graugaard-Jensen C., Senderovitz T., Norgaard J.P., and Djurhuus J.C. Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55-70 years. Eur J Clin Pharmacol 60 (2004) 397
53. Ferber R. Solve Your Child's Sleep Problems (1985), Simon and Schuster, New York 19
54. Minabe Y., Emori K., and Kurachi M. Effects of chronic treatment of methamphetamine and imipramine on amygdaloid seizure's generation. Jpn J Psychiatry Neurol 42 (1988) 337
55. Muller D., Roehr C.C., and Eggert P. Comparative tolerability of drug treatment for nocturnal enuresis in children. Drug Saf 27 (2004) 717
56. Cohen L.F., di Sant'Agnese P.A., Taylor A., and Gill Jr. J.R. The syndrome of inappropriate antidiuretic hormone secretion as a cause of hyponatremia in cystic fibrosis. J Pediatr 90 (1977) 574